title: [Using RevTet-On System to Control Thrombopoietin Gene Expression]
abstract: For the purpose of thrombocytopenia gene therapy, recombinant RevTet-On and pRevTRE/TPO retrovirus were packaged and transfected to NIH3T3 after selected with G418 and hygromycin, the two inserting recombinant retrovirus cell strain RevTet-On3T3/TPO were established. TPO expression was controlled and regulated by doxycydine (Dox). After using Dox to control the expression of TPO in RevTet-On3T3/TPO cells, the result showed that when Dox is added to the RevTet-On3T3/TPO cells, cell populations expressed TPO highly in the presence of 2 mg/L of Dox, and lowly in the absence of Dox. By using the RevTet-On gene expression system (the retrovirus vector RevTet-On regulation system to control the expression gene by Dox), it could modulate the expression of multiple genes by tetracyline and its derivatives. This system maybe provides a safe and efficacient way for the thrombocy to penia gene therapy.
authors.affiliation: Institute of Hematology, People's Hospital, Peking University, Beijing 100044, China.
authors.forename: Xudong
authors.initials: X
authors.lastname: Wei
authors.forename: Shuang
authors.initials: S
authors.lastname: Fu
authors.forename: Weiping
authors.initials: W
authors.lastname: Zang
authors.forename: Shasha
authors.initials: S
authors.lastname: Wu
authors.forename: Shenwu
authors.initials: S
authors.lastname: Wang
authors.forename: Debing
authors.initials: D
authors.lastname: Wang